Exchange: NYSE·Updated 05:26 PM EDT
DGX logo

DGXQuest Diagnostics, Inc.

$206.84
$0.82
(0.40%)
Today
Closed $206.84
$0.00
(0.00%)
After Hours
EarningsJul 23
Mkt Cap$22.99B
Vol691,871.00
News
all
press releases
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026
FAST, GD, UNH, TXRH and DGX are five stocks that combine long records of uninterrupted payouts with stable earnings and solid cash flow.
Zacks
More News
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus
DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.
Zacks
Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?
ABT heads into Q2 earnings results with growth expected across Diagnostics, Devices and EPD, while Nutrition remains a drag. Here's what could shape the results.
Zacks
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI
Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI PR Newswire SECAUCUS, N.J., July 8, 2026 American Oncology Network (AON) and other...
PR Newswire
Reminder - Quest Diagnostics (DGX) Goes Ex-Dividend Soon
Looking at the universe of stocks we cover at Dividend Channel, on 7/8/26, Quest Diagnostics, Inc. (Symbol: DGX) will trade ex-dividend, for its quarterly dividend of $0.86, payable on 7/22/26. As a percentage of DGX's recent stock price of $213.65, this dividend works out to a...
Nasdaq News: Markets
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks
Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus
Zacks highlights PDF Solutions, LifeStance Health and Paychex among stocks and portfolios that outperformed as markets weighed softer jobs data and earnings.
Zacks
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Quest Diagnostics (DGX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
Here is how Coya Therapeutics, Inc. (COYA) and Quest Diagnostics (DGX) have performed compared to their sector so far this year.
Zacks
<
1
2
...
>

Advertisement|Remove ads.